Nephrogenic calciphylaxis is associated with multiple risk factors including long-term dialysis dependence, hyperphosphatemia, hypercalcemia, parathyroid hormone derangements, vitamin K deficiency, obesity, diabetes mellitus, warfarin use, and female sex. Bariatric surgery is known to cause altered absorption, leading to mineral and hormonal abnormalities in addition to nutritional deficiency. Prior case reports on calciphylaxis development following bariatric surgery have been published, though are limited in number. We report a case series of five bariatric patients from a single institution who developed nephrogenic calciphylaxis between 2012 and 2018. These patients had a history of bariatric surgery, and at the time of calciphylaxis diagnosis, demonstrated laboratory abnormalities associated with surgery including hypercalcemia (n = 3), hyperparathyroidism (n = 2), hypoalbuminemia (n = 5), and vitamin D deficiency (n = 5), in addition to other medication exposures such as vitamin D supplementation (n = 2), calcium supplementation (n = 4), warfarin (n = 2), and intravenous iron (n = 1). Despite the multifactorial etiology of calciphylaxis and the many risk factors present in the subjects of this case series, we submit that bariatric surgery represents an additional potential risk factor for calciphylaxis directly stemming from the adverse impact of malabsorption and overuse of therapeutic supplementation. We draw attention to this phenomenon to encourage early consideration of calciphylaxis in the differential for painful skin lesions arising after bariatric surgery as swift intervention is essential for these high-risk patients.

1.
Nigwekar
SU
,
Thadhani
R
,
Brandenburg
VM
N Engl J Med
.
2018
;
378
(
18
):
1704
14
.
2.
Nigwekar
SU
,
Kroshinsky
D
,
Nazarian
RM
,
Goverman
J
,
Malhotra
R
,
Jackson
VA
et al
.
Calciphylaxis: risk factors, diagnosis, and treatment
.
Am J Kidney Dis
.
2015
;
66
(
1
):
133
46
.
3.
Chang
JJ
.
Calciphylaxis: diagnosis, pathogenesis, and treatment
.
Adv Skin Wound Care
.
2019
;
32
(
5
):
205
15
.
4.
Silva
ACF
,
Kazmarek
LM
,
Souza
EM
,
Cintra
ML
,
Teixeira
F
.
Dermatological manifestations relating to nutritional deficiencies after bariatric surgery: case report and integrative literature review
.
Sao Paulo Med J
.
2022
;
140
(
5
):
723
33
.
5.
O’Kane
M
,
Parretti
HM
,
Pinkney
J
,
Welbourn
R
,
Hughes
CA
,
Mok
J
et al
.
British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update
.
Obes Rev
.
2020 Nov
21
11
e13087
.
6.
Allegretti
AS
,
Nazarian
RM
,
Goverman
J
,
Nigwekar
SU
.
Calciphylaxis: a rare but fatal delayed complication of Roux-en-Y gastric bypass surgery
.
Am J Kidney Dis
.
2014
;
64
(
2
):
274
7
.
7.
Palal
B
,
Sinsakul
M
,
Reutrakul
S
.
Life-threatening hypocalcemia following subtotal parathyroidectomy in a patient with renal failure and previous roux-en-Y gastric bypass surgery
.
Case Rep Endocrinol
.
2011
;
2011
:
370583
.
8.
Bonatti
H
,
Iqbal
N
,
Kling
C
,
Melvin
W
,
Broome
J
.
Protracted hypocalcemia following 3.5 parathyroidectomy in a kidney pancreas recipient with a history of robotic-assisted roux-en-Y gastric bypass
.
Case Rep Transplant
.
2018
;
2018
:
2182083
.
9.
Cucka
B
,
Biglione
B
,
Ko
L
,
Nguyen
ED
,
Khoury
CC
,
Nigwekar
SU
et al
.
Calciphylaxis arising following bariatric surgery: a case series
.
JAAD Case Rep
.
2022
;
28
:
4
7
.
10.
Munavalli
G
,
Reisenauer
A
,
Moses
M
,
Kilroy
S
,
Arbiser
JL
.
Weight loss-induced calciphylaxis: potential role of matrix metalloproteinases
.
J Dermatol
.
2003
;
30
(
12
):
915
9
.
11.
Postorino
M
,
Marino
C
,
Tripepi
G
,
Zoccali
C
.
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease
.
J Am Coll Cardiol
.
2009 Apr 14
53
15
1265
72
.
12.
Nigwekar
SU
.
Calciphylaxis
.
Curr Opin Nephrol Hypertens
.
2017 Jul
26
4
276
281
.
13.
Rrapi
R
,
Chand
S
,
Gabel
C
,
Ko
L
,
Moore
KJ
,
Steele
D
,
Kroshinsky
D
.
Early diagnosis and intervention of calciphylaxis leading to rapid resolution
.
JAAD Case Rep
.
2021 Apr 24
13
65
70
.
14.
El-Saygeh
S
,
Roese
D
,
Moe
SM
.
Calciphylaxis or vascular oxalosis
.
Clin Kidney J
.
2020 Jan 18
14
1
435
8
.
15.
Witting
C
,
Langman
CB
,
Assimos
D
,
Baum
MA
,
Kausz
A
,
Milliner
D
et al
.
Pathophysiology and treatment of enteric hyperoxaluria
.
Clin J Am Soc Nephrol
.
2021 Mar 8
16
3
487
95
.
16.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group
.
KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
.
Kidney Int Suppl
.
2017 Jul
7
1
1
59
.
You do not currently have access to this content.